PI(4)K Inhibitor Could Prove Cure For Killer Diarrhoea

News   Jun 06, 2017 | Original Story from Novartis

 
A Cryptosporidium PI(4)K Inhibitor is a Drug Candidate for Cryptosporidiosis

Cryptosporidium parvum. Credit: EPA/H.D.A. Lindquist

 
 
 

RELATED ARTICLES

Lonza Expands Encapsulation and HPAPI Capabilities in North America

News

Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.

READ MORE

Fancy A Jellyfish Chip?

News

Mineral-rich jellyfish have been a staple in Asian cuisine for centuries, but remain an oddity to the western palate. Traditionally, they are marinated in salt and potassium alum for several weeks to produce a crunchy, pickle-like texture. Research have now developed a new technique that produces the same results in only a few days.

READ MORE

Bac­teria-Eat­ers to Pre­vent Food Pois­on­ing?

News

Bacteria-killing viruses could be employed not just in health care, but also in the food industry, a study indicates.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE